In addition, we compared the effects of different doses of BSHZF in PCOS-model rats and found that both CHM and CHH showed obvious therapeutic effects in ameliorating the clinical manifestations of PCOS and chronic inflammation. Here, CHM is linked to polycystic ovary syndrome.